ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase II Study of Iressa in Patients With Chemo Refractory Germ Cell Tumors Expressing EGFR (IUCRO-0021)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00198159
Recruitment Status : Terminated
First Posted : September 20, 2005
Last Update Posted : September 19, 2014
Sponsor:
Collaborator:
AstraZeneca
Information provided by:
Indiana University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : February 2006
  Actual Study Completion Date : March 2006